Compounding pharmacyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 16, 2026, FDA's public records list Key Pharmacy and Compounding Center with 79 drug recalls. The most recent is a drug recall dated Apr 18, 2017: PROCAINE HCL *5ML* SDV SULFITE FREE 1% INJ, Injection, 1%, RXxonly, 5mL Glass/Single Dos….
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Apr 18, 2017 | PROCAINE HCL *5ML* SDV SULFITE FREE 1% INJ, Injection, 1%, RXxonly, 5mL Glass/Single Dose vials, Prepared by Key Compounding PharmacyClass II · Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of | Drug recalls |
| Apr 18, 2017 | QUAD MIX 50/30/1/0.2 5ML MDV (CALIF) MCG/MG/MG/MG/ML INJ, Injection, 50mcg/30mg/1mg/0.2mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, PreparClass II · Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of | Drug recalls |
| Apr 18, 2017 | ALPHA LIPOIC ACID 25ML MDV 25MG/ML INJ, Injection, 25mg/mL, Rx only, 25 mL Glass/Multiple Dose vial, Prepared by Key Compounding PharmacyClass II · Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of | Drug recalls |
| Apr 18, 2017 | SODIUM CARBOXYM-CELL PF 0.5% OPHTH, opthalmic, 0.50%, Rx only, 10mL Glass/Multiple Dose vial, Prepared by Key Compounding PharmacyClass II · Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of | Drug recalls |
| Apr 18, 2017 | VITAMIN D3 IN OLIVE OIL SDV 100,000U/ML INJ, Injection, 150,000u/mL, Rx only, packaged in 2mL Glass/Single Dose vial, Prepared by Key CompouClass II · Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of | Drug recalls |
| Apr 18, 2017 | PGE1/PROCAINE 5ML MDV 20MCG/ML/0.1% INJ, Injection, 20mcg/ml 0.1%, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding PharmClass II · Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of | Drug recalls |
| Apr 18, 2017 | VITAMIN D3 IN OLIVE OIL SDV 100,000U/ML INJ, Injection, 100,000u/mL, Rx only, packaged in 1 mL Glass/Single Dose vial, Prepared by Key CompoClass II · Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of | Drug recalls |
| Apr 18, 2017 | PROCAINE HCL SDV 1% INJ, Injection, 1%, Rx only, packaged in 5mL and 50 mL Glass/Single Dose vials, Prepared by Key Compounding PharmacyClass II · Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of | Drug recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built